Page 10 - MI-2-1

Microbes & Immunity Antitumor targeting microenvironment

the authors and reviewers for their valuable contributions within the tumor microenvironment. Biochimie. 2023;212:
and insights, and the editorial staff for their support and 1-11.
assistance. We also invite the readers to peruse articles doi: 10.1016/j.biochi.2023.03.014
collected in this special issue and to share with us their 2. Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven
feedback and comments. metabolic adaptations guiding CD8 T cell anti-tumor
+
immunity. Immunity. 2023;56(1):32-42.
Conflict of interest
doi: 10.1016/j.immuni.2022.12.008
Xiaobo Wu is the editorial board member of this journal
and the guest editor of this special issue. The author declared 3. Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory
T cells as targets of cancer immunotherapy. Cancer Cell.
that he has no known competing financial interests or 2023;41(3):450-465.
personal relationships that could have influenced the work
reported in this paper. doi: 10.1016/j.ccell.2023.02.014
4. Zwergel C, Fioravanti R, Mai A. PD-L1 small-molecule
References modulators: A new hope in epigenetic-based multidrug
cancer therapy? Drug Discov Today. 2023;28(2):103435.
1. Rashid K, Ahmad A, Meerasa SS, et al. Cancer stem cell-
derived exosome-induced metastatic cancer: An orchestra doi: 10.1016/j.drudis.2022.103435

Volume 2 Issue 1 (2025) 2 doi: 10.36922/mi.4359